<DOC>
	<DOCNO>NCT03045497</DOCNO>
	<brief_summary>This pilot clinical trial compare use contrast-enhanced ultrasound contrast-enhanced magnetic response imaging ( MRI ) , current clinical standard , predict treatment response patient liver cancer receive transarterial chemoembolization drug elute bead . Comparing result diagnostic procedure transarterial chemoembolization may help doctor predict patient 's response treatment help plan best treatment . It yet know contrast-enhanced ultrasound work well contrast-enhanced MRI predict treatment response patient liver cancer .</brief_summary>
	<brief_title>Contrast-Enhanced Ultrasound Predicting Treatment Response Patients With Liver Cancer Receiving Transarterial Chemoembolization With Drug Eluting Beads</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . Evaluate contrast-enhanced ultrasound hepatocellular carcinomas one two week one month correlate clinical evaluation standard contrast-enhanced MRI one month ( current clinical standard ) patient undergone transarterial chemoembolization drug elute bead . SECONDARY OBJECTIVES : I . Establish whether change quantitative blood flow parameter relative baseline correlate effective embolization .</detailed_description>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>Be schedule transarterial chemoembolization use drug elute bead treatment hepatocellular carcinoma Be medically stable If female childbearing potential , must negative pregnancy test Have sign Informed Consent participate study Females pregnant nursing Patients medically unstable , patient seriously terminally ill , patient whose clinical course unpredictable ; example : Patients life support critical care unit Patients unstable occlusive disease ( eg , crescendo angina ) Patients clinically unstable cardiac arrhythmia , recurrent ventricular tachycardia Patients uncontrolled congestive heart failure ( New York Heart Association [ NYHA ] class IV ) Patients recent cerebral hemorrhage Patients clinically significant unstable renal disease ( eg , transplant recipient rejection ) Patients undergone surgery within 24 hour prior study sonographic examination Patients know hypersensitivity perflutren Patients receive contrast medium ( xray , MRI , compute tomography [ CT ] , ultrasound [ US ] ) 24 hour prior research US exam Patients cardiac shunt Patients congenital heart defect Patients severe emphysema , pulmonary vasculitis , history pulmonary embolus Patients respiratory distress syndrome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>